Atrial Fibrillation Trial, Recruiting NCT05773768 Sponsor: University Medical Center Groningen Condition: Atrial Fibrillation
Back to Atrial Fibrillation

Atrial Fibrillation Trial, Recruiting

NCT05773768
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been newly diagnosed with atrial fibrillation (an irregular heart rhythm), whether it comes and goes, has lasted a while, or is ongoing
  • People who are 65 years of age or older
  • People who are willing and able to take part and attend scheduled follow-up appointments

Who may not be able to join:

  • People whose atrial fibrillation was caused by a specific temporary trigger, such as a recent surgery, an infection, or an overactive thyroid gland
  • People who are not expected to live longer than one year
  • People who are currently taking part in another clinical study (participation in registry studies does not appear to count as an exclusion)
  • People with severe memory or thinking difficulties, such as advanced dementia, as measured by specific assessment tools used by the trial team

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
28 March 2024
Est. completion
1 January 2026

Where this trial is recruiting

🇳🇱 Netherlands

Primary endpoints

Identification and management of risk factors and comorbidities

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov